NCT02100332View on ClinicalTrials.gov

A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD)

CompletedOBSERVATIONAL

Enrollment

860

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Chronic Obstructive Pulmonary Disease

Trial Locations (1)

Unknown

Veruno (Novara)

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY

NCT02100332 - A Cross Sectional Disease/Condition Focused Observational Study on Chronic Obstructive Pulmonary Disease (COPD) | Biotech Hunter | Biotech Hunter